Patent · US Active

3,9-diazaspiro[5,5]undecane compound as FLT3 and AXL inhibitors

US11691974B2 · kind B2 · utility

1Cited by

0References

7Claims

0Family size

Assignee

Medshine Discovery Inc. · CN

Inventors

Xiangyu FU · Shanghai, CN
Charles Z. Ding · San Mateo, US
Lihong Hu · Shanghai, CN
Jianyu LU · Shanghai, CN
Wen Jiang · Shanghai, CN
Jian Li · Shanghai, CN
Shuhui CHEN · Shanghai, CN

Key dates

Filing date	Sep 27, 2019
Grant date	Jul 4, 2023
Priority date	—
Expiry date	Mar 9, 2040

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P35/02
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed in the present invention is a novel compound as FLT3 and AXL inhibitors. Specifically, disclosed are a compound represented by formula (I) and a pharmacologically acceptable salt thereof. (I)

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.